Kailera Therapeutics, Inc. Common Stock (KLRA) — Long-term Investment Intensity
Kailera Therapeutics, Inc. Common Stock (KLRA) has a Long-term Investment Intensity of 10.0% as of March 2026. Long-term investments of $62.75 Million represent 10.0% of total assets of $624.76 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Explore Kailera Therapeutics, Inc. Common Stock (KLRA) cash conversion ratio to assess how effectively this company generates cash.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Kailera Therapeutics, Inc. Common Stock Long-term Investment Intensity (2025–2025)
This chart shows how Kailera Therapeutics, Inc. Common Stock's Long-term Investment Intensity has evolved across 1 annual periods from 2025 to 2025. As of March 2026, the intensity stands at 10.0%, reflecting long-term investments of $62.75 Million against total assets of $624.76 Million USD. Explore Kailera Therapeutics, Inc. Common Stock (KLRA) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
Annual Long-term Investment Intensity for Kailera Therapeutics, Inc. Common Stock (2025–2025)
The table below presents the year-by-year Long-term Investment Intensity for Kailera Therapeutics, Inc. Common Stock from 2025 to 2025, covering 1 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see Kailera Therapeutics, Inc. Common Stock stock valuation.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2025 | 15.4% | $106.67 Million | $692.29 Million | — |